Xudong Kong

Tenure-track Associate Professor

  • Tel: +86-021
  • Email: xudong.kong@sjtu.edu.cn
  • Address: 2-409, Zhangheng Road 429, Postcode 201203, Pudong District, Shanghai, China
  • Our research focuses on protein and peptide evolution based on phage display and next-generation sequencing technologies.

Education and Research Experience

Education background

  • Jul. 2009 – Apr. 2015 PhD in Biochemical Engineering

Supervisors: Dr. Prof. Jian-He Xu, Dr. Prof. Jiahai Zhou

Bioengineering School

East China University of Science & Technology, China

Shanghai Institute of Organic Chemistry, China

  • Sep. 2005 – Jun. 2009 BSc in Bioengineering

Supervisors: Dr. Prof. Jian-He Xu, Dr. Jiang Pan

Bioengineering School

East China University of Science & Technology, China

Appointment

  • August 2020 – present Tenure Track Associate Professor

School of Life Sciences and Technology

Shanghai Jiao Tong University, China

  • May 2015 – July 2020 Postdoctoral Scientist

Supervisor: Dr. Prof. Christian Heinis

Laboratory of Therapeutic Proteins and Peptides

Institute of Chemical Sciences and Engineering

EPFL, Switzerland

Research Interests

Protein fitness landscape analysis

Protein fitness landscape analysis based on phage display and next-generation sequencing techniques.

Development of orally available peptide drugs

Improve bioavailability of peptide drugs by the evolution of peptide stability and permeability.

Selected Publications

  • Guo, Q.; Zeng, H.;Kong, X.D.#Phage Selection of Cyclic Peptides Inhibiting Aminoglycoside Phosphotransferases to Control Resistant Bacteria.ACS Chem. Biol.2025, 20, 2219−2228.

    Ma, B.D.; Li, J.Y.; Xu, J.H.; Yu, T.;Kong, X.D.#ADP-ribose is a competitive inhibitor of methanol dehydrogenases from Bacillus methanolicus.J. Biol. Chem.2025, 110599.

    Han, Y., Luo, Y., Ma, B.D., Li, J.#, Xu, J.H.#andKong, X.D.#Structural Insights of a cis-Epoxysuccinate Hydrolase Facilitate the Development of Robust Biocatalysts for the Production of l-(+)-Tartrate.Biochem., 2024, doi:10.1021/acs.biochem.4c00141

    Zhu, X.X., Zheng, W.Q., Xia, Z.W., Chen, X.R., Jin, T., Ding, X.W., Chen, F.F., Chen, Q., Xu, J.H.Kong, X.D.#and Zheng, G.W.#Evolutionary insights into the stereoselectivity of imine reductases based on ancestral sequence reconstruction.Nat. Commun., 2024, 15, 10330.

    He, R.N., Zhang, M.J., Dai B.#andKong, X.D.#Selection of Peptide−Bismuth Bicycles Using Phage Display.ACS Chem. Biol.2024, doi: 10.1021/acschembio.4c00099

  • Sun, C.*, Ma, B.D.*, Li, G., Tian, W., Yang, L., Peng, H., Lin, Z., Deng, Z.,Kong, X.D.#and Qu, X.#Engineering the substrate specificity of a P450 dimerase enables the collective biosynthesis of heterodimeric tryptophan-containing diketopiperazines.Angew Chem. Int. Ed., 2023, e202304994.

    Kong, X.D., Carle, V., Díaz-Perlas, C., Butler, K., Heinis, C.#Generation of a large peptide phage display library by self-ligation of whole-plasmid PCR product.ACS Chem. Biol., 2020, 15, 2907–2915.

    Kale, S.S.*, Villequey, C.*,Kong, X.D.*, Zorzi, A., Deyle, K., Heinis, C#. Cyclization of peptides with two chemical bridges affords large scaffold diversities.Nat. Chem., 2018, 10, 715-723.

    Kong, X.D., Moriya, J., Carle, V., Pojer, F., Abriata, L.A., Deyle, K., Heinis, C. De novo development of proteolytically resistant therapeutic peptides for oral administration.Nat. Biomed. Eng., 2020, 4, 560–571.

    Kong, X.D.#; Zhang, M.J.; Heinis, C#. Phage Display Selection against a Mixture of Protein Targets.ACS Chem. Biol.2025, 20, 6, 1288–1297.

Teaching Experiences

  • Biochemistry F (fall semester)
Baidu
map